Clinical Trials Browser

Phase 2 × R-CHOP protocol × 90 days × Clear all

NCT04546620 2026-04-30

REMoDL-A

Phase 2 Active not recruiting

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07494565 2026-03-27

Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL

Phase 2 Not yet recruiting

Lymphoma, Large B-Cell, Diffuse